





























Link to publication record in King's Research Portal
Citation for published version (APA):
Gatta, A., & Carlton, J. G. (2019). The ESCRT-machinery: closing holes and expanding roles. Current Opinion in
Cell Biology, 59, 121-132. https://doi.org/10.1016/j.ceb.2019.04.005
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
 1 
The ESCRT-machinery: closing holes and expanding roles 1 
 2 
Alberto T Gatta1,2 and Jeremy G Carlton*1,2 3 
 4 
1. Division of Cancer Studies 5 
School of Cancer and Pharmaceutical Sciences 6 
King’s College London 7 
London 8 
SE1 1UL 9 
 10 
2. The Francis Crick Institute 11 
1 Midland Road 12 
London 13 
NW1 1AT 14 
 15 
 Contact: jeremy.carlton@kcl.ac.uk 16 
 17 
Abstract 18 
The ESCRT machinery is an ancient, evolutionarily conserved membrane remodelling complex 19 
that is deployed by cells to perform a diverse collection of physiological and 20 
pathophysiological processes. ESCRT proteins are needed for multivesicular body biogenesis, 21 
release of enveloped retroviruses, reformation of the nuclear envelope and cytokinetic 22 
abscission during mitotic exit. These events all share the requirement for a topologically 23 
equivalent membrane remodelling for their completion that is thought to be performed by 24 
ESCRT-III. More recently, ESCRTs have been shown to play an essential roles in repairing 25 
damaged cellular membranes, so preserving cellular viability and organellar function. Here, 26 
we will examine new advances in our understanding of the cell biology of this fascinating 27 
cellular machinery.  28 
 29 
  30 
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Introduction 31 
The Endosomal Sorting Complex Required for Transport (ESCRT) machinery [Table 1] is an 32 
evolutionarily conserved multi-subunit membrane remodelling complex. Whilst these 33 
proteins were discovered originally for their role in regulating degradative endosomal sorting, 34 
the surprise finding of recent years is the cellular employment of this machinery in a variety 35 
of essential roles that contribute to normal physiology and pathophysiology. ESCRTs, it seems, 36 
really are everywhere [1]. For a detailed analysis of ESCRT biology and function, we refer 37 
readers to recent excellent in depth reviews [2,3] and we will explore here some more recent 38 
advances in this exciting and fast-moving field.  39 
 40 
How do ESCRT proteins remodel membranes? 41 
The ESCRT complex is responsible for many membrane remodelling processes essential for 42 
cell physiology including intraluminal vesicle (ILV) formation, viral budding, cytokinetic 43 
abscission, exosome release, and repair of membrane fenestrations. These processes all share 44 
the requirement for the scission of a cytoplasm filled membranous stalk for their completion 45 
(Figure 1A and Figure 1B) [1-3]. Assembly of the ESCRT machinery proceeds as a recruitment 46 
cascade originating with site-specific adaptors such as endosomal proteins and ubiquitinated 47 
cargoes for MVB biogenesis, midbody components for cytokinesis or viral Gag proteins for 48 
retroviral egress. These components trigger recruitment of early-acting ESCRT factors, such 49 
as ALIX for cytokinesis, or ESCRT-I/ESCRT-II for MVB biogenesis, which concentrate cargoes, 50 
initiate membrane bending and nucleate the assembly of ESCRT-III components.  ESCRT-III 51 
proteins form a membrane-interacting oligomeric filament that is thought to operate the 52 
membrane remodelling event, eventually resulting in scission [2-4]. The biological reasons 53 
behind the evolution of 8 different ESCRT-III subunits (with additional homologues present in 54 
humans bringing the total number to 12, see Table 1 and Figure 1C) remain unknown. 55 
However, some ESCRT-III subunits are recruited only to a site-specific filament, e.g. CHMP7 is 56 
thought to nucleate the filament for nuclear envelope resealing [5]. Studies in Saccharomyces 57 
cerevisiae and studies of HIV-1 release showed that the indispensable components of the 58 
filaments are the ESCRT-III proteins Snf7/CHMP4, Vps24/CHMP3, and Vps2/CHMP2 and the 59 
hexameric AAA ATPase, Vps4, that is proposed to drive membrane remodelling through a 60 
variety of mechanisms [6-8].  61 
 62 
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ESCRT-III subunits are thought to adopt two distinct conformations, referred to as ‘open’ or 63 
‘closed’. These were believed to represent membrane-adsorbed or soluble conformations, 64 
with transition between the two states regulated by displacement of a C-terminal regulatory 65 
region (Figure 1C) [9].  The structure of the ESCRT-III filament has recently been visualised in 66 
three different approaches, but many details remain unclear. McCullough et al. used a cryo-67 
EM approach to generate a 4 Å resolution reconstruction of a heteropolymeric filament of 68 
open CHMP1B with the closed-conformation N-terminus of IST1 [10]. This architecture 69 
clarified how ESCRT-III spiralling structure could stabilise membranes with different degrees 70 
of curvature. Whilst we commonly associate ESCRT-III-activity with ‘reverse topology’ 71 
membrane scission, this structure revealed that the CHMP1B/IST1 heteropolymer was able 72 
to coat ‘normal topology’ membrane tubules [10], suggesting that the ESCRT-III filament may 73 
be more plastic than originally thought. Two other structures of the filament elucidated the 74 
similar intermolecular packing mechanisms of the activated filament-forming Snf7/CHMP4 75 
protein [11] and its fly homologue Shrub [12] indicating that subunits polymerized into a 76 
staggered, nested array. Both structures agreed on the intermolecular interactions required 77 
for the polymerisation, however these truncated CHMP4 versions lacked the C-terminal 78 
regulatory region and Vps4-interacting motifs, and resulted in linear crystal packing (while in 79 
vivo they bind to negatively curved membranes). How other ESCRT-III subunits interact to 80 
perform the membrane remodelling remains to be established. The last approach used a 81 
combination of electron microscopy and atomic force microscopy (AFM) to study the 82 
mechanical properties of Snf7/CHMP4 filament on supported lipid bilayer [13,14]. Curved 83 
Snf7/CHMP4 filaments grew radially on supported membranes so to act as a ‘spiral spring’ 84 
with the stored elastic energy increasing in the growing filament as growth forced the 85 
adoption of non-preferred curvatures, with this energy proposed to remodel membranes 86 
[14]. In this scenario, the activity of Vps4 contributed to constant turnover of ESCRT-III 87 
subunits within the growing filaments (both of Snf7 and of Vps2/Vps24 to enable effective 88 
filament growth [13]. In recent work by Hurley and Bustamante laboratories [4], a minimal 89 
ESCRT-III machinery was encapsulated inside giant unilamellar vesicles and optical tweezers 90 
were applied to pull lipid nanotubes to create a reverse-curvature topology in which to 91 
visualise ESCRT-III activity. This technique allowed the measurement of the forces generated 92 
by Snf7/CHMP4, Vps2/CHMP2, and Vps24/CHMP3 in the presence of Vps4 and ATP 93 
confirming that (i) the full set of proteins and ATP were necessary and sufficient for force 94 
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generation within the tube; and (ii) active Vps4, visualised in fluorescent ESCRT-III/Vps4 95 
puncta along the tube, and consequent ATP hydrolysis were essential to induce nanotube 96 
scission. These data provide the first topologically correct in vitro reconstitution of ESCRT-III 97 
activity and we hope future combinations of biophysical approaches with minimal system 98 
reconstitutions and ultrastructural microscopy will enable full understanding of the 99 
composition and dynamics of the ESCRT-III filament, as well as the structural and mechanical 100 
bases of force generation. 101 
 102 
Kinetics and dynamics of ESCRT assembly 103 
New insights into the behaviour of ESCRT complexes on endosomes  104 
ESCRT activity is the only mechanism by which transmembrane cargo that has escaped the 105 
secretory pathway can be degraded. Understanding the biology of ESCRT function on 106 
endosomes has proved a rich arena. Technological advances have provided greater insight 107 
into the behaviour of these proteins on endosomes and a number of high spatial and temporal 108 
resolution studies have helped us understand how this machinery acts. Whilst ILV-containing 109 
multivesicular endosomes (MVEs) are commonly thought to be ‘late’ endosomes, Raiborg and 110 
colleagues showed recently that ESCRT components were recruited within 2-5 minutes of 111 
stimulation, and showed maximal colocalization within 15 minutes of stimulation, suggesting 112 
that degradative fate is encoded early in the endosomal lifecycle [15]. Rather than being 113 
constantly present on endosomes, waves of early ESCRT-0 or ESCRT-I recruitment, and 114 
transient waves of later-acting ESCRT-III components were observed on the same endosome. 115 
These data suggesting that multiple rounds of ILV biogenesis occur at the same site and that 116 
there is temporal coordination between cargo-sorting and membrane fission activities. 117 
Correlative light and electron microscopy suggested that each ESCRT recruitment wave 118 
resulted in the generation of individual ILVs, indicating that repeated recruitment waves 119 
would permit the sequential generation of multiple ILVs within a single endosome (Figure 2) 120 
[15]. Consistent with this, in worms [16] and plants [17], individual ILVs have been observed 121 
to be concatenated, suggesting that they bud continuously from stable endosomal 122 
microdomains. Concatenated ILVs were stable and the concatenations themselves appear 123 
sufficient to restrict diffusion of membrane bound cargo back to the endosomal limiting 124 
membrane without requiring scission [17]. Whether a proteinaceous tether acts to stabilise 125 
these concatenations is unclear, but persistent ESCRT-III in the neck would be ideally placed 126 
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to perform this function. These data tell us that the terminal membrane fission event thought 127 
to release vesicles need not actually occur with each round of budding and may speak to an 128 
intrinsic inefficiency in the fission process. This can best be appreciated by examining the 129 
ESCRT-dependence of HIV-1 release. Using an elegant cytosolic pH cycling system to 130 
temporally pinpoint virion and cytosol separation, Simon and colleagues have shown recently 131 
that not all virions are released upon the 1st round of ESCRT-recruitment and that multiple 132 
waves can be necessary to decouple virion content from cytosol [18]. Tellingly, in these 133 
studies, total internal reflection microscopy imaging revealed that ESCRT-III and VPS4 134 
disappeared from the site of fission prior to virion release [18]. These data indicate that 135 
ESCRT-III’s role is to stabilise a narrow neck, but need to get out of the way before fission 136 
occurs, suggesting that they may be blocking formation of a hemifusion intermediate within 137 
the neck. Perhaps, in the context of concatenated vesicles, the next wave of budding occurs 138 
before ESCRT-III is properly removed. 139 
 140 
To investigate the dynamics and assembly of individual ESCRT-III components upon 141 
endosomes, Teis and colleagues employed lattice light sheet (LLS) microscopy of yeast 142 
bearing endogenously tagged ESCRT components. Rather than being recruited after ESCRT-143 
III, as predicted from previous studies and the expectation that Vps4 acts as a disassembly 144 
factor, Vps4 and ESCRT-III were found to be temporally co-recruited [19]. These data indicate 145 
that endosomal ESCRT-III assemblies were remodelled by Vps4 throughout the ILV-generation 146 
process and that Vps4 is doing more than just recycling this machinery. Endosomal 147 
recruitment events were surprisingly transient, lasting between 3 and 45 seconds, however, 148 
the majority of these events were deemed ‘unproductive’ as they were observed to occur in 149 
the presence of ATPase-defective Vps4, and upon endosomes too small to permit ILV 150 
generation. A subset of recruitment events accumulated 3 or more Vps4 hexamers and up to 151 
200 Snf7 molecules, and were posited to represent productive ILV biogenesis events [19]. 152 
These data have parallels with recent biochemical and cell biological findings showing Vps4 153 
acting to exchange monomers throughout the growth and remodelling of an ESCRT-III 154 
filament [13]. Using high-speed AFM, Roux and colleagues observed that co-polymers of Snf7 155 
and Vps2/Vps24 actually assembled in vitro as separate intertwined homotypic spirals [13], 156 
consistent with the observed co-recruitment of Vps24, Snf7 and Vps4 from LLS data [19]. 157 
These data argue against the behaviour of Vps2/Vps24 as a capping subunit and Vps4 as a 158 
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terminal disassembly factor and suggest that these proteins may act together throughout the 159 
ILV biogenesis cycle. Thus, rather than a stochastic activity on later endocytic structures, cargo 160 
presence on early endosomes templates the biogenesis of a ‘degradative domain’ from where 161 
repeated cycles of ILV generation can occur and can, in some cases, can lead to the generation 162 
of concatenated ILVs. Cargo-concentrating ESCRT-0 and -I complexes are recruited first, 163 
followed by transient co-recruitment of ESCRT-III subunits and Vps4. If sufficient ESCRT-III and 164 
Vps4 molecules are recruited, a productive budding event will ensue (Figure 2).  165 
 166 
ESCRTs on endosomes – integration with other machineries 167 
ESCRTs aren’t the only PtdIns(3)P-coordinated sorting machinery on endosomes. As well as 168 
degradative cargo sorting to the ILV, retromer and the sorting nexins act to extract cargo from 169 
these organelles for recycling back to the plasma membrane, or retrieval to the Golgi [20]. 170 
Whilst ubiquitination is a dominant signal for ESCRT-dependent degradation, it is not obvious 171 
how this pathway is coordinated with recycling or retrieval pathways. Although it is a key 172 
initiator of degradation, the ESCRT-0 component HRS localises the actin nucleator WASH to 173 
endosomes [21]. Endosomal actin can support the generation of sorting-nexin-derived 174 
tubulovesicular carriers exiting endosomes for cargo recycling, and an actin-binding motif 175 
countered ubiquitination to regulate the balance of recycling versus degradation at this 176 
organelle [21]. In worms, removing retromer allows ESCRT coverage to expand on endosomes 177 
leading to the inappropriate degradation of cargoes that are usually recycled [22], suggesting 178 
that entry into this degradative pathway may not be as regulated as we once thought. 179 
Endosomes from cells lacking the ESCRT-III component IST1 display more recycling tubules 180 
and it was found that IST1-dependent recruitment of Spastin acted to sever these tubules 181 
from endosomes [23]. In recent years, it has been shown that this occurs at contact sites with 182 
the ER [24]. These data suggest that the sorting machineries that regulate these trafficking 183 
decisions do not act in as isolated manner as we may think, that cytoskeletal elements such 184 
as actin may help control the balance between recycling and degradation. Future research 185 
efforts ought integrate the biology of sorting complexes acting at these small organelles. 186 
 187 
ESCRTs in cell division  188 
Membrane abscission during cytokinesis 189 
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ESCRTs are critical mediators of the abscission step of cytokinesis [25-27] and the discovery 190 
that this pathway operates in archaea [28] suggest an ancestral role for this machinery in cell 191 
division (Figure 3). Mimicking recent discoveries of a contributing role for ESCRT-II in HIV-1 192 
release [29], it appears that cells have two alternate routes for assembling ESCRT-III at the 193 
midbody downstream of the midbody component CEP55 – one relies upon ALIX as an adaptor 194 
protein between CEP55 and ESCRT-III [26,30] and the other involves an link via ESCRT-I, -II 195 
and CHMP6 [31,32]. In recent years, progress has been made in visualising the dynamics and 196 
regulation of ESCRT assembly at the midbody. Using cryo-electron microscopy [27], and soft 197 
X-ray tomography [33], telling spirals have been observed in the midbodies of cells in 198 
cytokinesis, leading to the speculation that contractile ESCRT-III rings narrowed the midbody 199 
to a point of fission. Using 3D-STORM and illuminating endogenous ESCRT-III components, 200 
the Elia lab have now documented the existence of helical ESCRT-III filaments and 201 
characterised their changes during cytokinetic progression; from the initial 2-ring stage where 202 
a large 1 µm diameter ring assembles adjacent to the dark zone, to progressively narrowing 203 
ring-like structures that appeared in some cases to be connected as a narrowing spiral [34]. 204 
As observed previously [35,36], the generation of a secondary pool of ESCRT-III rings was 205 
observed at the abscission site. These data suggest that ESCRT-III constriction mediates the 206 
membrane remodelling required for cytokinesis by narrowing the midbody through the 207 
creation of helical filaments on the inside of the midbody membrane. Whilst ESCRTs may 208 
constrict the midbody membrane, it is becoming clear that for this to happen, cortical actin 209 
within the midbody must also be remodelled. In this manner, there appears a balance 210 
between formin-mediated actin polymerisation and capping protein (CP)-mediated 211 
suppression of filamentous actin that is required for proper cytokinesis; in the absence of CP, 212 
persistent F-actin led to midbodies that failed to narrow and  properly assemble ESCRT-III into 213 
ring like structures for division [37]. Midbody actin is also depolymerised through the action 214 
of MICAL1, an enzyme that catalyses oxidation of methionine residues in actin [38]. MICAL1 215 
is recruited and activated by midbody Rab35 and MICAL1-depenent actin depolymerisation 216 
is necessary for the formation of the secondary pool of ESCRT-III at the site of abscission. 217 
However, it is also to be noted that RhoA and Citron Kinase-dependent F-actin has been 218 
reported to stabilise these secondary ingressions for ESCRT-III dependent abscission [39], 219 
highlighting the need to understand the complex dynamics of actin at these sites. Future 220 
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research will hopefully integrate actin, microtubules, ESCRTs and other filament forming 221 
machineries such as the septins into a general model for abscission. 222 
 223 
Control of the abscission checkpoint 224 
Although cells must complete cytokinesis for effective cell division, there exists an Aurora B-225 
dependent abscission checkpoint [40] that operates through the centralspindlin component 226 
MKLP1 [40] and phosphorylation of CHMP4C [41,42] to retard abscission. A variety of stimuli 227 
can engage this checkpoint, including defects in chromosome segregation, impaired NPC 228 
assembly and even tension at the midbody [43] and it is hypothesised that engagement of 229 
this checkpoint gives cells more time to resolve these problems before completing the 230 
division process. Alongside Aurora B, other kinases including ULK3 [44], the CLKs [45] and the 231 
ESCRT-associated protein ANCHR [46] play roles in checkpoint engagement. Mechanistically, 232 
this checkpoint appears to operate by suppressing ESCRT-III polymerisation and retaining 233 
VPS4 within the central region of the midbody [41,46]. Cell division checkpoints act typically 234 
to protect the genome from chromosome segregation errors and subsequent aneuploidy. In 235 
this regard, CHMP4C has been identified in a GWAS as a susceptibility locus for ovarian cancer 236 
[47] and a single nucleotide polymorphism (rs35094336) in CHMP4C that is associated with a 237 
number of cancers encodes a non-synonymous mutation in CHMP4C (A232T). This mutation 238 
impairs interaction with ALIX and cells bearing CHMP4CA232T are checkpoint blind and 239 
accumulate DNA damage, chromosome segregation errors and aneuploidy [48]. These data 240 
suggest a molecular explanation for the cancer susceptibility of this polymorphism. CHMP4C 241 
has also been proposed to localise to unattached kinetochores and to participate in proper 242 
chromosome segregation by controlling the mitotic spindle assembly checkpoint (SAC) [49], 243 
which could provide an alternate explanation for the involvement of this protein in cancer 244 
susceptibility. However, CHMP4C knockout cells displayed an intact SAC [48] and this and 245 
previous studies did not report gross chromosome mis-segregation upon CHMP4C depletion 246 
[41], suggesting that that involvement of this protein in mitotic checkpoints warrants further 247 
study. 248 
 249 
ESCRTs at centrosomes 250 
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ESCRT-depletion has been reported to alter both centrosome and spindle pole numbers [26], 251 
suggesting previously unappreciated roles for these proteins in regulating these membrane-252 
less organelles. VPS4 has been localised to these structures [50,51] and an ATPase defective 253 
form of VPS4 reduced γ-tubulin levels, impaired centrosome dynamics and compromised 254 
ciliogenesis. Whilst the ATPase activity of VPS4 was needed, ESCRT-III was dispensable for 255 
these functions, suggesting that VPS4 may remodel non-ESCRT-III proteins to effect 256 
centrosome dynamics and so regulate cell and tissue organisation.  257 
 258 
ESCRTs at the nuclear envelope 259 
ESCRTs also operate at the nuclear envelope in a brief 2-4-minute window during mitotic exit. 260 
Here, they seal small holes in the reforming nuclear envelope and coordinate this with 261 
removal of spindle-microtubules that are enveloped by ER-sheets as they wrap daughter 262 
nuclei [5,52]. Just as specific adaptors recruit ESCRT-III to endosomes (HRS/ESCRT-0), the 263 
midbody (CEP55) and sites of viral budding (viral L-domains), during division a specific adaptor 264 
recruits ESCRT-III to the reforming nuclear envelope. In this case, the adaptor is CHMP7 [5], a 265 
hybrid ESCRT-II/ESCRT-III-like protein that harbours an ER-localising and membrane-binding 266 
motif in its N-terminal VPS25-like domain [53]. CHMP7 is recruited by LEM2 (Heh1 and Heh2 267 
in yeast) and is essential for localising downstream ESCRT-III components to this organelle 268 
[53-55] to effect membrane sealing and nuclear compartmentalisation. Additionally, through 269 
IST1, ESCRT-III is able to recruit the microtubule severing enzyme, Spastin, to depolymerise 270 
microtubules and coordinate spindle disassembly with membrane sealing [5]. ESCRT-III thus 271 
plays an essential role in both generating and maintaining nucleocytoplasmic 272 
compartmentalisation and for protecting the genome from cytoplasmic insults. More 273 
recently, a role for the CHMP4-binding protein CC2D1B has been observed in the regulation 274 
of ESCRT-III activity at this site. CC2D1B is part of the Lgd/CC2D1 family of proteins that binds 275 
and controls polymerisation of CHMP4 proteins [56,57]. CC2D1B binds both CHMP7 and, via 276 
a C-terminal C2-domain, the membrane lipid PtdIns(4,5)P2, and assembles at the reforming 277 
nuclear envelope in a CHMP7-dependent manner [58]. In the absence of CC2D1B, premature 278 
and temporally mal-coordinated ESCRT-III and Spastin recruitment at the reforming nuclear 279 
envelope is observed, suggesting that this protein ensures timely polymerisation of ESCRT-III 280 
at this organelle, necessary for proper nuclear envelope regeneration.  281 
 282 
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Open mitoses give organisms opportunity to assess the quality of their nuclear pore 283 
complexes, long lived structures that are built for life and that regulate nucleo-cytoplasmic 284 
compartmentalisation and exchange. Organisms such as S. cerevisiae undergo a closed 285 
mitosis and employ ESCRT-III as a surveillance mechanism to sequester defective NPC 286 
components preventing them short-circuiting the normal transport activities at the nuclear 287 
envelope [59]. The exact mechanism of this surveillance and extraction is the subject of active 288 
study, but may involve sealing of a double membrane over the defective NPCs in an ESCRT-289 
III-dependent manner [60]. These data nicely rationalise the disparate ESCRT functions at this 290 
organelle, but yeast undergoing a closed mitosis are not the only cells that need to survey 291 
their NPCs – quiescent and terminally differentiated cells will no longer have a mitotic 292 
opportunity to address problems in compartmentalisation. Using an elegant Cre-mediated 293 
switch of tagged protein expression to track old and new proteins in quiescent C2C12 muscle 294 
cells, Hetzer and colleagues recently showed that ESCRT-III-dependent whole NPC turnover 295 
occurs to replace these complexes [61], suggesting an evolutionary conservation of ESCRT-III-296 
dependent NPC surveillance from yeast to mammals. 297 
 298 
In interphase cells, ESCRT-III also repairs nuclear envelope ruptures that occur during 299 
constrained migration, helping to maintain cellular viability and protection of the genome 300 
[55,62,63]. More recently, it has been shown that viruses that need to cross this membrane 301 
employ nucleoplasmic ESCRT proteins to bud across the inner nuclear membrane (INM) and 302 
then subsequently fuse with the outer nuclear membrane to effect traversal of this double 303 
membrane barrier. ESCRTs had been previously implicated in the lifecycle of herpes viruses 304 
such as Epstein Barr Virus (EBV) as the viral protein BFRF1 recruited ALIX and other ESCRT-III 305 
proteins to the nuclear envelope [64]. More recently, ALIX and ESCRT-III, but not CHMP7, 306 
were shown to be necessary for Herpes Simplex Virus-1 (HSV-1) nuclear export [65]. HSV-1 307 
UL34, the positional orthologue of EBV BFRF1, bound directly to ALIX, recruited downstream 308 
ESCRT-III proteins and was necessary for budding of HSV-1 across the INM. Interestingly, 309 
removal of ESCRT proteins led to INM expansion in cultured cells, suggesting that ESCRT 310 
participates in a continual remodelling of this organelle [65]. ESCRTs thus play important roles 311 
in controlling membrane integrity and organellar homeostasis at the nucleus and may 312 
participate in the NPC-independent transit of ribonucleoprotein particles across these 313 
membranes [65,66].  314 
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ESCRTs as controllers of membrane integrity 315 
As well as regulating degradative cargo sorting and membrane remodelling during cell 316 
division, an essential role for ESCRT-III in controlling membrane integrity is emerging. For 317 
many years, we have known that ESCRT-III can repair damaged regions of plasma membrane 318 
and so preserve cellular viability [67,68]. Plasma membrane damage can be induced by 319 
interaction with the microenvironment or other external forces. However, it has now become 320 
clear that pathophysiological processes can also induce plasma membrane damage that is 321 
repaired in an ESCRT-dependent manner [69,70]  (Figure  1A). Surprisingly, necroptosis and  322 
pyroptosis, forms of programmed cell death,  were both  antagonised by ESCRT-III activity. 323 
During pyroptosis, caspase-dependent cleavage of cellular gasdermin-D creates a pore-324 
forming fragment that can permeabilise the plasma membrane [69]. During necroptosis, 325 
mixed lineage kinase like (MLKL) activation can trigger plasma membrane disruption [70], and 326 
ESCRT-III-dependent membrane repair acted to both limit pyroptotic cell death and prevent 327 
release of further inflammatory mediators. It is hypothesised that pore-containing regions of 328 
plasma membrane are shed in ectosomes in an ESCRT-dependent manner. The biology of 329 
non-viral release of plasma membrane buds is poorly understood, but we know that ESCRT 330 
proteins can assemble here [71,72]. In the case of MLKL activation, ectosomes containing 331 
externalised phosphadidylserine were released in an ESCRT-dependent manner [70], 332 
suggesting this as a mechanism to antagonise MLKL-dependent necroptosis.  333 
 334 
Having initiated a cell death programme, it is not immediately clear why cells would choose 335 
to step back from the brink and choose life once more. However, upon removal of MLKL 336 
activation stimuli, this is exactly what was observed and perhaps represents and adaptive 337 
response to a suicide signal, allowing resuscitation should it be required. Necroptosis, unlike 338 
apoptosis, is an immunogenic cell death and, in the case of MLKL-activation, ESCRT-339 
dependent repair gave cells time to alter their transcriptome, synthesise and secrete 340 
inflammatory cytokines and chemokines to facilitate cross priming of CD8+ T-cells to alert and 341 
activate the immune system [70]. So, whilst ESCRT proteins have a variety of roles in normal 342 
physiology, they also play new and important roles in protection from pathophysiological 343 
insults that trigger pathways such as necroptosis.  344 
 345 
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It isn’t just the plasma membrane that can get damaged though, cells are constantly sampling 346 
their microenvironment, internalising extracellular content and trafficking it to lysosomes for 347 
degradation and release of nutrients. However, some internalised materials such as uric acid 348 
crystals, asbestos fibres, or lysosomotropic agents, can damage endosomes and compromise 349 
endosomal function. Many pathogens access the cytosol by disrupting endosomal 350 
membranes, whereas other acidophilic pathogens want to maintain endosomal integrity so 351 
that they can replicate effectively in the lysosome. As such, maintaining endosomal and 352 
lysosomal integrity is an essential physiological process, and one that is exploited by 353 
pathogens. Hanson and Stenmark labs have shown recently that upon addition of 354 
lysosomotopic agents that can damage endolysosomal membranes, ESCRT-III components 355 
were rapidly recruited to endosomes and acted to repair these holes [73,74]. Unrepaired 356 
holes allowed the recruitment of cytosolic galectins, permitting recognition by the autophagy 357 
machinery and subsequent organellar degradation. As such, ESCRT-III acts in this context as a 358 
molecular puncture repair kit, mending small holes in damaged organelles, preserving their 359 
function. ESCRT-III thus has an unexpected role in promoting cell survival and, as well as 360 
sorting cargo for lysosomal degradation, provides an activity to ensure that these organelles 361 
are competent to degrade cargo. The recruitment signal for this repair activity is currently 362 
unclear, but paralleling pathways of ESCRT-III recruitment during cytokinesis, TSG101 and 363 
ALIX provide redundant mechanisms to assemble ESCRT-III on damaged endolysosomes 364 
[73,74]. However, ESCRT-III recruitment to effect lysosomal repair was wortmannin 365 
insensitive [73] and independent of HRS [75], suggesting that an alternate endolysosomal 366 
adaptor upstream of ALIX and TSG101 exists to orchestrate this recruitment. ESCRT-III 367 
recruitment to these sites of damage has been described to be calcium dependent [73,75] 368 
and the calcium-binding protein ALG2 has been previously implicated in recruitment of 369 
ESCRT-III to effect repair of regions of damaged plasma membrane [68,76]. However, 370 
alternate reports suggest the calcium independence of this endosomal repair pathway 371 
[74,77] and whether ALG2 represents this adaptor awaits experimental validation.  372 
 373 
A number of pathogens usurp the endosomal system to access the cytoplasm by using the 374 
low pH to trigger endolysosomal rupture. Mycobacterium tuberculosis employs a Type VII 375 
secretion system (T7SS) to rupture endosomal membranes and allow cytosolic replication. 376 
ESCRT-III is recruited to endosomes damaged by M. tuberculosis, and disrupting the T7SS to 377 
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prevent membrane damage abrogated this recruitment [75]. M. tuberculosis injects secreted 378 
effectors through its T7SS to modify host-cell biology and enable replication. Two of these 379 
proteins, a heterodimer of EsxG and EsxH, interact with HRS [78]. Although recruitment of 380 
ESCRT-III to damaged endolysosomes was independent of HRS, EsxG/EsxH could impair 381 
ESCRT-III assembly at sites of endolysosomal damage in M. Tuberculosis infected cells and in 382 
situations of sterile damage [75]. A related endomembrane repair function for ESCRTs was 383 
revealed upon infection of Dictyostelium discoideum with the mycobacteria Mycobacterium 384 
marinum. Here, TSG101, CHMP4 and VPS4 were recruited to sites of phagosomal 385 
endomembrane damage induced by M. marinum’s ESX1 secretion system [77].  386 
 387 
Interestingly, pathogens entering cells through the endosomal system need to escape before 388 
they are degraded by the acidic lysosome [79]. Antagonism of ESCRT function may provide 389 
access to the cytoplasm, but will also neutralise endolysosomal acidification to prevent 390 
pathogen degradation in this compartment. Other pathogens, such as Coxiella burnetii 391 
actively seek an acidic endolysosomal environment in which to replicate. Compromising 392 
ESCRT-dependent endolysosomal repair impaired C. burnetii replication, suggesting that 393 
some pathogens exploit this repair pathway to create an environment that actually favours 394 
their replication [74].  395 
 396 
ESCRTs are typically thought to close holes in double membraned organelles, and the 397 
topology of membrane damage in a single membraned organelle, such as the endosomal 398 
limiting membrane or the plasma membrane, creates a topological quandary (Figure 3i). It 399 
has been hypothesised that budding of damaged regions out of the plasma membrane may 400 
provide the topology for ESCRT-III to work on, but it is not obvious how these budded 401 
structures would be generated. Perhaps an analogous situation occurs at endosomes where 402 
damaged regions are incorporated into budding ILVs to take advantage of this natural process 403 
(Figure 3ii)? Reports of pathogen-induced damage causing the budding into vacuoles and 404 
extrusion of macroscopic regions of damaged plasma membrane suggest that canonical 405 
ESCRT-III-mediated budding may indeed effect removal of these damaged regions [77]. 406 
However, it is not immediately obvious that torn or damaged membranes could support the 407 
biophysical changes required to remodel them into vesicles, and ESCRT-III-dependent 408 
endolysosomal repair seems independent of factors such as PtdIns(3)P or HRS that normally 409 
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initiate ILV biogenesis. As well as budded spiral structures that are thought to assemble within 410 
membranous necks, ESCRT-III has been observed to form planar spirals on membranes 411 
[72,80]. Perhaps a physiological role for these planar spirals is to provide a platform over 412 
regions of damaged membrane from which to flow new membrane in for repair (Figure 3iii)?  413 
 414 
ESCRTs as regulators of unconventional secretion 415 
Whilst the intraluminal vesicles of MVEs represent an important intermediate in the 416 
degradation of membrane bound cargo, MVEs can also fuse with the plasma membrane to 417 
release these vesicles as exosomes to the extracellular environment (Figure 1A). Exosomes 418 
are but one class of extracellular vesicle but are clinically and physiologically important as 419 
they have the potential as biomarkers to report on organismal physiology and 420 
pathophysiology, and though cell-cell communication, to influence the behaviour of tissues 421 
distal to the site of production [81]. How the cell decides whether to fuse its MVEs with the 422 
plasma membrane or with lysosomes, and whether this decision is subject to physiological 423 
regulation, is a major outstanding question for the field. However, the small GTPases Rab27a 424 
and Rab27b are key mediators of MVE size and docking with the plasma membrane [82] and 425 
the target SNAREs Syntaxin-4 and SNAP23 are also required [83]. Although ESCRT-426 
independent routes of sorting cargo to ILVs have been reported [84], ESCRT represents the 427 
major determinant of both the biogenesis and cargo loading onto ILVs, and thus onto 428 
exosomes [85]. In the absence of proper ESCRT function, both the quality and the quantity of 429 
released exosomes will differ. For example, CHMP1A is needed for release of extracellular 430 
vesicles containing, amongst other cargoes, the signalling morphogen sonic hedgehog (SHH) 431 
[86], paralleling reports that ESCRTs are key mediators of hedgehog release in D. 432 
melanogaster [87]. Loss of CHMP1A function leads to disrupted SHH signalling and defects in 433 
cortical neural progenitor proliferation which may underlie the microcephaly with 434 
pontocerebellar hypoplasia observed in patients bearing loss-of-function mutations in 435 
CHMP1A [88]. Other cargos can be sorted into ILVs, and thus exosomes, by virtue of 436 
interaction with core ESCRT components. The soluble lectin GAL3 contains a P(S/T)AP motif 437 
and is incorporated into ILV and exosomes though direct interaction with TSG101 [89], 438 
suggesting that this pathway can select soluble cargo. In addition to core ESCRT components, 439 
ESCRT-interacting adaptor proteins such as ALIX can also regulate cargo incorporation into 440 
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exosomes. A PDZ-domain containing adaptor protein called Syntenin binds ALIX’s V-domain 441 
by mimicking a LYPxL-type viral late domain [90] and through coordination of PDZ-ligand 442 
proteins such as syndecan, these proteins control cargo import into exosomes. ILVs can form 443 
in the absence of ALIX, but it seems their quality is altered. For example, PD-L1, a key 444 
immunosuppressive molecule that allows many cancers to avoid the immune system, has 445 
recently been described to be secreted upon exosomes [91-93] and  is incorporated into 446 
exosomes in an ALIX-dependent manner [91]. Exosomally secreted PD-L1 could inhibit CD8+ 447 
T-cell activation and facilitate melanoma progression, could used as a biomarker to stratify 448 
melanoma patients [92] and could be transferred to multiple cell types in the tumour 449 
microenvironment to mediate active immunosuppression [93]. Consistent with finding that 450 
reduction of ESCRT activity led to enhanced presentation of hedgehog at the plasma 451 
membrane in flies [87], depletion of ALIX led to impaired ILV and exosome incorporation of 452 
PD-L1 and enhanced surface presentation and immunosuppression in mammalian cancer 453 
cells [91]. These data suggest that for MVEs that will fuse with the plasma membrane, ESCRT-454 
dependent sorting from limiting membrane to ILV will determine the balance between 455 
exosome and plasma membrane presentation of these secreted cargos (Figure 1A).  456 
 457 
ESCRTs have a long history of being peripherally required for autophagy, but only recently has 458 
ESCRT-III been demonstrated to play a role in autophagosome closure [94] – a long 459 
hypothesised function given the requirement to close a double membraned autophagosome 460 
[1]. ESCRTs thus seem necessary for proper autophagic degradation of cargo. 461 
Autophagosomes normally fuse with lysosomes for cargo degradation but, like MVEs for 462 
exosome secretion, autophagosomes can also fuse with the plasma membrane to effect an 463 
unconventional secretory pathway called secretory autophagy [95] Additionally, in S. 464 
cerevisiae the compartment for unconventional protein secretion (CUPS) pathway generates 465 
multilamellar structures that are secreted bypassing the ER in an ESCRT-dependent, but Vps4-466 
independent manner [96]. Whether this pathway exists in higher organisms is unknown, but 467 
these data highlight the utility of ESCRT proteins for generating closed membranous 468 




In recent years, the ESCRT machinery has come to be appreciated as a transplantable 472 
membrane remodelling machinery, deployed by the cell in a variety of contexts to effect a 473 
toplogically unique membrane fission. Whilst cell biological approaches have told us what this 474 
machinery can do, recent advances in biophysical approaches have begun to shed light on the 475 
question of exactly how ESCRT proteins catalyse this membrane separation step. 476 
Computational models have been helpful in understanding how membrane remodelling can 477 
occur, but will likely have to be refined to encompass all the biology we now know ESCRTs are 478 
capable of performing. We commonly ascribe a membrane deformation ability to ESCRT-III, 479 
based upon the need to remodel the endosomal limiting membrane into an inwardly budding 480 
intermediate from which an ILV will be generated. However, it seems that ILV generation may 481 
be a topological anomaly and that the majority of situations in which ESCRT-III acts (nuclear 482 
envelope sealing, cytokinesis, viral release, autophagosome closure) do not require this 483 
deformation as the membranous stalk that ESCRTs are to sever is pre-existing. In the case of 484 
viral budding, the L-domain phenotype is budded stalks that can’t be severed and it is intuitive 485 
to see how a myristolated sphere of Gag will remodel the membrane by itself. Recent 486 
anisotropic measurement of sfGFP-Gag shows membrane bending occurs throughout the 487 
transition of a flat Gag lattice to a sphere, with ESCRT-III arrival (and departure) only seen 488 
immediately prior to scission [18]. Understanding how ESCRT-III polymers transition between 489 
flat and 3-dimensional filaments will be important for understanding the biophysical basis for 490 
ESCRT-III function and  systems to interrogate ESCRT activity within pre-existing stalks [4] will 491 
hopefully provide the basis to understanding the elusive molecular basis of this fascinating 492 
membrane fission activity.  493 
 494 
Figure Legends 495 
Figure 1: Major membrane remodelling pathways performed by the ESCRT machinery in 496 
cells. A. Topological equivalence of membrane fission events induced by ESCRT-III in cells 497 
including intraluminal vesicle formation upon endosomes (allowing their subsequent release 498 
as exosomes when endosomes fuse with the plasma membrane), release of viruses such as 499 
HIV-1, sealing of holes in the nuclear envelope (in interphase and in mitosis), repair of plasma 500 
(and organellar – see Figure 3) membranes. In addition to these events, ESCRT-III also plays 501 
roles in autophagosome closure, neuronal pruning and surveillance of nuclear pore 502 
complexes [1]. B. ESCRT-III is thought to assemble as a membrane remodelling 3-dimensional 503 
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spiral that severs membrane necks, leading to the separation of previously joined 504 
membranes. C. Schematic representation of secondary structural elements in human ESCRT-505 
III proteins. The blocks show helices whose boundaries were determined from a combination 506 
of known structures and predicted results. Helices α1-α4 corresponding to the core structural 507 
components of ESCRT-III filaments are shown in purple to green colours, downstream 508 
regulatory elements are shown in red and yellow as in Bajorek et al. (2009) [97]. Additional 509 
features, such as C-terminal MIM2 motifs for CHMP4B and CHMP6, or additional helices for 510 
IST1, are shown in white blocks. Predictions were obtained by building a multiple sequence 511 
alignment of all ESCRT-III primary sequences with MUSCLE [98] and submitting this MSA to 512 
the PSIPRED-based Ali2D software [99]. α2 and α3 were predicted as a continuous helices and 513 
manually separated based on available crystal structures. 514 
 515 
Figure 2: Kinetics and dynamics of ESCRT functions on endosomes. Intraluminal vesicle 516 
formation is thought to occur from a stable, clathrin-enriched, microdomain on endosomes. 517 
Waves of ESCRT-recruitment underlie the biogenesis of individual ILVs [15]. In plants and 518 
worms [16,17], ILVs have been observed to be concatenated and/or tethered by membranes, 519 
suggesting that the terminal fission event for ILV release may not be absolutely required 520 
during each round of biogenesis.  521 
 522 
Figure 3: ESCRT-III-dependent membrane repair. ESCRT-III is proposed to repair minor 523 
damage to the plasma membrane and endolysosomes (depicted here). Organellar damage 524 
leads to breakdown in compartmentalisation and function. ESCRT-III is recruited to damaged 525 
endolysosomes to effect repair. The mechanism of repair is unknown, but may involve: 526 
ESCRT-III assembley inside a fenestration in a single membrane (i), damaged regions being 527 
incorporated into reverse topology buds for classical ESCRT-III-mediated scission (ii), or planar 528 
ESCRT-III assemblies may provide a platform for repair. If repair fails, endolysosomes are 529 
targeted for degradation by autophagy.  530 
 531 
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have a protective role to suppress forms of cell death induced through plasma membrane 561 
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